Maxcyte, Inc.
MXCT- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001287098
No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Maxcyte, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +24 vs. Q3 2021
- Shares held
- 67.2M
- +12.6M (+23.1%) vs. Q3 2021
- Total value
- $683.6M
- +$18.4M (+2.8%) vs. Q3 2021
- New holders
- 35
- 43 more added
- Sold out
- 11
- 16 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MXCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $78.0M |
| Q1 2026 | 132 | $46.2M |
| Q4 2025 | 112 | $98.0M |
| Q3 2025 | 112 | $110.8M |
| Q2 2025 | 120 | $155.5M |
| Q1 2025 | 115 | $193.8M |
| Q4 2024 | 119 | $301.9M |
| Q3 2024 | 120 | $267.4M |
| Q2 2024 | 114 | $268.0M |
| Q1 2024 | 124 | $280.8M |
| Q4 2023 | 121 | $316.1M |
| Q3 2023 | 120 | $200.8M |
| Q2 2023 | 116 | $303.3M |
| Q1 2023 | 115 | $327.9M |
| Q4 2022 | 105 | $377.7M |
| Q3 2022 | 109 | $453.8M |
| Q2 2022 | 104 | $322.7M |
| Q1 2022 | 99 | $479.8M |
| Q4 2021 | 104 | $683.6M |
| Q3 2021 | 81 | $665.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Maxcyte, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 5,214,464 | $53.1M | 0.00% | +4,535,552+668.1% | Added |
| Casdin Capital, LLC | 13,971,334 | $142.4M | 4.01% | 00.0% | Unchanged |
| Bank of Montreal | 524 | – | – | +524 | New |
| Quilter Plc | 4,400 | – | – | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −805,823−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −422,442−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| AREX Capital Management, LP | 0 | $0 | 0.00% | −126,968−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −87,076−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −31,600−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −25,512−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −9,904−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −171−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |